High Hampton Holdings Corp Share Price Canadian Securities Exchange
Equities
CA42966X3094
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 563K 413K 32.86M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | - |
Net cash position 2022 | 841K 617K 49.06M | Net cash position 2023 | 690K 506K 40.26M | EV / Sales 2023 | - |
P/E ratio 2022 |
22.9
x | P/E ratio 2023 |
-8.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.53% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 25/09/23 |
Director of Finance/CFO | 53 | 18/09/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 53 | 18/09/23 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 25/09/23 |
Anderson Shannon
BRD | Director/Board Member | - | 18/09/23 |
1st Jan change | Capi. | |
---|---|---|
+29.64% | 682B | |
+31.23% | 586B | |
-3.29% | 364B | |
+17.94% | 327B | |
+4.03% | 285B | |
+16.72% | 240B | |
+10.02% | 209B | |
-8.75% | 203B | |
+7.41% | 165B |